Bristol-Myers Squibb

Yahoo Finance • 3 hours ago

Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status

Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers Squibb announced a development in its Alzheimer’s program: its experimental drug, BMS-986446, received Fast Track d... Full story

Yahoo Finance • 21 hours ago

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 22 hours ago

Sector Update: Health Care Stocks Decline Friday Afternoon

Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • yesterday

Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal

Bristol-Myers Squibb (BMY) on Friday agreed to acquire privately-held ribonucleic acid medication ma PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • yesterday

Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives

BMS and NCPA to address cardiovascular disease and enhance patient care coordination with specialized training in rural Alabama, Arkansas, Kentucky, Louisiana, Mississippi, and Missouri pharmacies Originally published on NCPA.org NORTHAM... Full story

Yahoo Finance • yesterday

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further strengthens BMS’s industry-leading ce... Full story

Yahoo Finance • 2 days ago

What Do Recent Medicare Negotiation Plans Mean for Bristol-Myers Squibb Shares in 2025?

Thinking about what to do with Bristol-Myers Squibb stock? You are certainly not alone. With shares closing recently at $44.54, there has been plenty to talk about, especially as the stock has faced some turbulence throughout 2025. Over th... Full story

Yahoo Finance • 4 days ago

Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO

Worawith Ounpeng MapLight Therapeutics (MPLT [https://seekingalpha.com/symbol/MPLT]), whose lead candidate ML-007C-MA could potentially rival Bristol Myers’ (BMY [https://seekingalpha.com/symbol/BMY]) recently approved antipsychotic Coben... Full story

Yahoo Finance • 4 days ago

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Bristol-Myers Squibb Company (N... Full story

Yahoo Finance • 4 days ago

TMC Crosses Above Average Analyst Target

In recent trading, shares of TMC The Metals Co Inc (Symbol: TMC) have crossed above the average analyst 12-month target price of $7.69, changing hands for $7.72/share. When a stock reaches the target an analyst has set, the analyst logica... Full story

Yahoo Finance • 5 days ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Plug Power Inc. 155,000,553 4.58 3.85 3.8888 +0.0788 Advanced Micro Devi... Full story

Yahoo Finance • 6 days ago

Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now.Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks Bristol-Myers Squibb Company (NYSE:BMY) is a... Full story

Yahoo Finance • 6 days ago

SA Asks: What's the most attractive Big Pharma stock right now?

[Pfizer HQ in New York City] georgeclerk What's the most attractive Big Pharma stock right now? We asked Seeking Alpha analysts The Value Portfolio [https://seekingalpha.com/author/the-value-portfolio] and ALLKA Research [https://seeking... Full story

Yahoo Finance • 7 days ago

Pfizer – TrumpRx deal boosts Big Pharma to a record rally

[President Trump Delivers An Announcement From The Oval Office] Win McNamee/Getty Images News The world’s biggest pharma companies recorded their best weekly performance in years on Friday after Pfizer (NYSE:PFE [https://seekingalpha.com/... Full story

Yahoo Finance • 7 days ago

How Investors Are Reacting To Veeva Systems (VEEV) Winning Bristol Myers Squibb as a Vault CRM Client

Bristol Myers Squibb recently announced its adoption of Veeva Systems' Vault CRM, underscoring Veeva’s growing presence in life sciences cloud software among top biopharma companies worldwide. This trend highlights a significant shift towa... Full story

Yahoo Finance • 8 days ago

Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery

Bristol-Myers Squibb Company (NYSE:BMY) is one of the most undervalued stocks to buy and hold for 5 years. On October 1, Bristol-Myers Squibb, Takeda Pharmaceuticals (NYSE:TAK), and Astex Pharmaceuticals agreed to collaborate and pool prop... Full story

Yahoo Finance • 9 days ago

Bristol-Myers Squibb (BMY) Is Up 7.4% After FDA Fast Track Win for Alzheimer’s Drug Candidate

Bristol-Myers Squibb announced that its investigational anti-tau antibody BMS-986446, aimed at early Alzheimer's disease, received Fast Track Designation from the FDA, a regulatory milestone intended to expedite the drug's development and... Full story

Yahoo Finance • 9 days ago

Bristol Myers Alzheimer's Drug Earns FDA Fast Track

This article first appeared on GuruFocus. Bristol Myers Squibb (NYSE:BMY) just got a boost in its Alzheimer's program after the FDA granted Fast Track designation to its experimental drug BMS-986446, now in phase 2 testing for patients in... Full story

Yahoo Finance • 9 days ago

Bristol-Myers Squibb (BMY) Reports Strong Multiple Myeloma Data

Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top picks for a retirement portfolio. Bristol-Myers Squibb Company (NYSE:BMY) reported on September 23 that its Phase 3 EXCALIBER-RRMM trial using iberdomide combined with daratumumab... Full story

Yahoo Finance • 10 days ago

Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Directly to Cash-Paying U.S. Customers

With significant upside potential, Bristol-Myers Squibb Company (NYSE:BMY) secures a spot on our list of the 20 NYSE Stocks with the Lowest P/E Ratios.Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Direc... Full story